Characterisation of chronic obstructive pulmonary disease (COPD) in never-smokers and ever-smokers from a population-based cohort

Read full text
Authors: Pernilla Sönnerfors, Petra Kristina Jacobson, Anders Andersson, Leif Hilding Bjermer, Anders Blomberg, Heléne Blomqvist, Jonas S. Erjefält, Iryna Kolosenko, Andrei Malinovschi, T. Pincikova, Ellen Tufvesson, Åsa M. Wheelock
+3 more Christer Janson, H L Persson, Magnus Carl Sköld
Cited by: 1
References: 28

Abstract

Background Chronic obstructive pulmonary disease (COPD) in never-smokers may have other clinical characteristics than tobacco smoking-related COPD. Research question What are the risk factors, biomarkers, respiratory symptoms and health status in never-smoking individuals with COPD? Study design and methods We investigated never-smokers with COPD (n=154, mean age 60 years) from the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS), and compared them with four control groups: never-smokers with normal lung function (n=281), current smokers with normal lung function (n=97), ex-smokers with COPD (n=103) and current smokers with COPD (n=55). COPD was defined as forced expiratory volume in 1 s (FEV 1 )/forced vital capacity (FVC) less than the lower limit of normal (LNN) after bronchodilation. We examined fractional exhaled nitric oxide (FeNO), blood biomarkers, respiratory symptoms, health status, medical history and living conditions. Results The never-smoker COPD group reported more respiratory symptoms and worse health status than never-smokers with normal lung function, but fewer symptoms, milder airflow limitation and better health status compared with ex-smokers and smokers with COPD. Never-smokers with COPD had more self-reported asthma. Moreover, never-smokers with COPD had higher Immunoglobulin E sensitisations to a mix of aeroallergens, higher geometrical mean FeNO levels and blood eosinophil counts than never-smokers with normal lung function. When participants with self-reported asthma were excluded, never-smokers with COPD still had more wheeze, cough and higher FeNO. Conclusion Never-smokers with COPD had more respiratory symptoms and elevated markers of type-2 inflammation, suggesting they might represent a distinct clinical phenotype which may differ from smoking-related COPD. They may therefore need to be treated and followed differently. Trial registration number NCT03049202 .

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Smoking Behavior and Cessation Inhalation and Respiratory Drug Delivery

Publication details

Journal / source
BMJ Open Respiratory Research
Publisher
BMJ
Volume
13
Issue
1
Pages
e003578–e003578
Publication date
1 February 2026
Language
EN